Jill Hessler
Facial Plastic Surgery · Palo Alto, CANPI 1922043074
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (44.7%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. AbbVie accounts for 68.5% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2022 at $31,864 and has fallen 95.4% since, to $1,473 in 2025. Among facial plastic surgery clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 347 payments — averaging $329.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$78K
- Galderma Laboratories, L.p.$32K
- Merz North America, Inc.$4K
- Revance Therapeutics, Inc.$237
- Polarityte, Inc.$50
- Solta Medical, A Division Of Bausch Health US, LLC$23
- plus $23 from 1 others
What the payments were for
- Consulting fees$36,21032%
- Speaking & faculty fees$51,14745%
- Travel & lodging$15,62214%
- Food & beverage$11,42510%
- Education$590%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 178 | $78,391 |
| Galderma Laboratories, L.p. | 104 | $31,829 |
| Merz North America, Inc. | 58 | $3,909 |
| Revance Therapeutics, Inc. | 4 | $237 |
| Polarityte, Inc. | 1 | $50 |
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $23 |
| Kls-martin L.p. | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$114,463 in reported general payments places this provider in the 95th percentile of 120 facial plastic surgery providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 17 | $827 |
| Celecoxib | 15 | $418 |
| Alprazolam | 11 | $35 |
Paid to pharmacies, not to this prescriber.
Other facial plastic surgery in Palo Alto
- Brittany LeaderPalo Alto$4K
- Dominick GadaletaPalo Alto$2K
- Daryoush SaadatValencia$1.3M
- Kian KarimiLos Angeles$1.2M
- Rami BatnijiNewport Beach$1M
- Victor LacombeSanta Rosa$106K
- Alen CohenWest Hills$72K
- Bradley GreenePortola Valley$52K
- Geoffrey TrenkleLos Angeles$44K
- Elbert ChengSaratoga$38K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.